3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
34
Neoplasms
17
Breast Neoplasms
15
Carcinoma, Non-Small-Cell Lung
5
Polycystic Ovary Syndrome
4
Lymphoma
4
Sarcopenia
3
Prostatic Neoplasms
3
Lung Neoplasms
3
Fatigue
3
Colorectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Ovarian Neoplasms
2
Obesity
2
Malnutrition
2
Lymphedema
2
Insulin Resistance
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Weight Cycling
1
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Interventions
pembrolizumab
20
Gemcitabine
18
Cisplatin
14
enfortumab vedotin
12
Magnetic Resonance Spectroscopy
12
Specimen Handling
10
Cystectomy
10
Docetaxel
8
Mitomycin
7
Standard of Care
6
Cystoscopy
6
Transurethral Resection of Bladder
5
Radiotherapy
5
Carboplatin
5
durvalumab
4
Practice Guidelines as Topic
4
Nivolumab
4
Radiation
3
Multiparametric Magnetic Resonance Imaging
3
Mitozytrex
3
Fluorouracil
3
tislelizumab
2
dehydroftorafur
2
cemiplimab
2
avelumab
2
alvimopan
2
Therapeutics
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Urinary Bladder Neoplasms
×
Exercise
×
Clear all
NCT05715684
2023-03-22
Prehab
Dana-Farber Cancer Institute
Phase NA
Recruiting
25 enrolled